The Enterprise Value as of September 2024 (TTM) for Jasper Therapeutics, Inc. (JSPR) is 242.01M

According to Jasper Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 242.01M. This represents a change of 100.54% compared to the average of 120.68M of the last 4 quarters.

Jasper Therapeutics, Inc. (JSPR) Historical Enterprise Value (quarterly & annually)

How has JSPR Enterprise Value performed in the past?

The mean historical Enterprise Value of Jasper Therapeutics, Inc. over the last ten years is -5746440.83. The current 242.01M Enterprise Value has changed -421252.13% with respect to the historical average. Over the past ten years (40 quarters), JSPR's Enterprise Value was at its highest in in the December 2020 quarter at 3.77B. The Enterprise Value was at its lowest in in the September 2023 quarter at -24048482.00.

Jasper Therapeutics, Inc. (JSPR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Jasper Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Jasper Therapeutics, Inc. (JSPR) Average Enterprise Value

How has JSPR Enterprise Value performed in the past?

The current Enterprise Value of Jasper Therapeutics, Inc. (JSPR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Jasper Therapeutics, Inc. (JSPR) Enterprise Value vs. Peers

How is JSPR’s Enterprise Value compared to its peers?

Jasper Therapeutics, Inc.’s Enterprise Value is greater than Lyra Therapeutics, Inc. (23.16M), greater than Equillium, Inc. (20.02M), greater than HOOKIPA Pharma Inc. (91.29M), greater than LianBio (-66141903.00), greater than Acumen Pharmaceuticals, Inc. (112.86M), greater than Galera Therapeutics, Inc. (-5796499.00), less than Inozyme Pharma, Inc. (407.26M), greater than Eledon Pharmaceuticals, Inc. (77.32M), less than Icosavax, Inc. (713.87M), less than Edgewise Therapeutics, Inc. (1.54B), greater than Ikena Oncology, Inc. (47.83M), less than Design Therapeutics, Inc. (271.25M), greater than Xilio Therapeutics, Inc. (-30542416.00), less than Eliem Therapeutics, Inc. (329.54M), less than POINT Biopharma Global Inc. (0), less than ORIC Pharmaceuticals, Inc. (1.32B), less than Inhibrx, Inc. (657.66M), greater than ESSA Pharma Inc. (27.63M), greater than null (224.94M),

Build a custom stock screener for Jasper Therapeutics, Inc. (JSPR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jasper Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jasper Therapeutics, Inc. (JSPR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jasper Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.